Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nordic Longterm OCD treatment study of aripiprazole augmentation after CBT and sertraline failure
2009-011115-20Phase 2Active
- Sponsor
- RBUP Øst og Sør
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of aripiprazole and sertraline in obsessive compulsive disorder (OCD), sponsored by RBUP Øst og Sør. Primary endpoints: CY-BOCS score at 8 weeks after inclusion in step 3, CY-BOCS score at 3 months after inclusion in step 3 and 5 more. Started Apr 2009; status: active.
02
Drugs
aripiprazolesertraline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on 2009-011115-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011115-20.